These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 14101323)

  • 1. A CONTROLLED CLINICAL TRIAL OF ISONIAZID AND HETEROCYCLIC THIOSEMICARBAZONE COMPARED WITH ISONIAZID AND PAS IN PULMONARY TUBERCULOSIS.
    JANCIK E; TOUSEK J; MAKOVA M; ZELENKA M
    Tubercle; 1963 Dec; 44():431-42. PubMed ID: 14101323
    [No Abstract]   [Full Text] [Related]  

  • 2. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 3. CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    MOODIE AS; SISTER AQUINAS ; FOORD RD
    Tubercle; 1964 Sep; 45():192-201. PubMed ID: 14227804
    [No Abstract]   [Full Text] [Related]  

  • 4. [TRIPLE SCHEMA IN THE TREATMENT OF TUBERCULOSIS].
    LAUROC DE
    Rev Paul Med; 1964 Jan; 64():57-62. PubMed ID: 14137921
    [No Abstract]   [Full Text] [Related]  

  • 5. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 6. [DETERMINATION OF RESISTANCE OF TUBERCLE BACILLI IN THE TUBE DILUTION TEST AND VERTICAL DIFFUSION TEST].
    KOCH H
    Z Arztl Fortbild (Jena); 1964 May; 58():481-4. PubMed ID: 14227086
    [No Abstract]   [Full Text] [Related]  

  • 7. [SIDE-EFFECTS OF ANTIBACTERIAL PREPARATIONS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
    VILDERMAN AM; EVGRAFOVA ZA; REZNIK SE; FINN ER
    Klin Med (Mosk); 1963 Dec; 41():36-42. PubMed ID: 14148115
    [No Abstract]   [Full Text] [Related]  

  • 8. THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.
    STEWART SM; CROFTON JW
    Am Rev Respir Dis; 1964 Jun; 89():811-29. PubMed ID: 14169411
    [No Abstract]   [Full Text] [Related]  

  • 9. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 10. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 11. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 12. PRIMARY DRUG RESISTANCE.
    SINGH B
    Acta Tuberc Pneumol Scand; 1964; 45():70-6. PubMed ID: 14209271
    [No Abstract]   [Full Text] [Related]  

  • 13. [PRIMARY BACTERIAL RESISTANCE].
    IANELLO JA
    Torax; 1963; 12():154-6. PubMed ID: 14158176
    [No Abstract]   [Full Text] [Related]  

  • 14. [BACTERIOLOGICAL FINDINGS IN SUBJECTS AFFECTED BY CHRONIC PULMONARY TUBERCULOSIS (FINDINGS ON PATIENTS HOSPITALIZED IN THE ISTITUTO "C. FORLANINI" IN THE 3 YEAR PERIOD 1960-62)].
    ZUBIANI M; LUCCHESI M
    Arch Tisiol Mal Appar Respir; 1964 Aug; 19():650-5. PubMed ID: 14253925
    [No Abstract]   [Full Text] [Related]  

  • 15. ANONYMOUS MYCOBACTERIA ISOLATED FROM CLINICAL SPECIMENS IN HONG KONG.
    WONG PC
    J Trop Med Hyg; 1964 Apr; 67():100-2. PubMed ID: 14135612
    [No Abstract]   [Full Text] [Related]  

  • 16. SPECIFIC DRUG THERAPY IN PULMONARY TUBERCULOSIS: ILLUSTRATED BY CLINICAL, RADIOLOGICAL, BACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS IN RESECTED PATIENTS.
    NESET G
    Acta Chir Scand Suppl; 1964; 20():SUPPL 335:1-94. PubMed ID: 14265539
    [No Abstract]   [Full Text] [Related]  

  • 17. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
    VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H
    Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913
    [No Abstract]   [Full Text] [Related]  

  • 18. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 19. ISONIAZID-INDUCED ENCEPHALOPATHY.
    ADAMS P; WHITE C
    Lancet; 1965 Mar; 1(7387):680-2. PubMed ID: 14258550
    [No Abstract]   [Full Text] [Related]  

  • 20. [TREATMENT WITH FIRST LINE DRUGS (S.M.), (I.N.H.) AND (P.A.S.) IN PATIENTS WITH PULMONARY TUBERCULOSIS NEVER TREATED BEFORE].
    PEREZ JA; FARIAS CE
    Sem Med; 1963 Aug; 123():452-9. PubMed ID: 14088086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.